- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04934306
Nasalance Scores for Normal-speaking French Children (NONAFRA2022)
Normative Nasalance Scores for Native French-speaking Children
The velopharyngeal mechanisms (in particular the movements of the soft palate) is frequently affected by craniofacial anomalies such as cleft lip and palate. Nasofibroscopy is frequently used in clinical care to assess the velopharyngeal function because it allows for direct visualization of the velopharyngeal port. However, it is an invasive procedure that could not be tolerated well by children.
Nasometry is a non-invasive acoustic measurement technique which can be used to objectively assess a velopharyngeal dysfunction (whether it can be heard or not), and thus supplement the perceptual evaluation conducted by a trained clinician.
The main objective of this study is to establish normative nasalance scores with the KayPENTAX Nasometer (Nasometer II 6450 model) for native French-speaking children between 8 and 10 years old.
Study Overview
Detailed Description
The velopharyngeal mechanism (in particular the movements of the soft palate) is frequently affected by craniofacial anomalies such as cleft lip and palate and it needs to be assessed. Indeed, the velopharyngeal sphincter has to be efficient in order to properly isolate the oral cavity from the nasal cavity. Thus, the nasal cavity is protected during swallowing (preventing food or liquids from passing through the nose). It also ensures a correct phonation and articulation of oral phonemes.
A perceptual evaluation of the velopharyngeal function is always conducted by a clinician. But it is a subjective assessment which may need to be supplemented by an objective instrumental assessment. Nasofibroscopy is frequently used in clinical care to evaluate the velopharyngeal function because it allows for direct visualization of the velopharyngeal port. However, it is an invasive procedure that could not be tolerated well by children.
Nasometry on the other hand is a non-invasive acoustic measurement technique. It is based on the relation between nasal and oral acoustic energy and determines a nasalance score. Calculated in real time during speech production, the nasalance is a measure expressed as a percentage : (nasal acoustic energy) / (sum of oral and nasal acoustic energy). The device computing the nasalance score is called a Nasometer.
Thus, in addition to the speech therapist's perceptual evaluation, nasometry can be used to objectively assess and quantify a velopharyngeal dysfunction whether it can be heard or not. However in order to determine if a patient's nasalance score is pathological or not, it must be compared to standardized norms. Yet presently, there are no normative nasalance data for French-speaking children. The main objective of this study is to establish normative nasalance scores with the KayPENTAX Nasometer (Nasometer II 6450 model) for native French-speaking children between 8 and 10 years old.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Contact
- Name: Natacha KADLUB, MD, PhD
- Phone Number: +33 1 71 39 67 54
- Email: natacha.kadlub@aphp.fr
Study Contact Backup
- Name: Hélène Morel
- Phone Number: +33 1 71 19 63 46
- Email: helene.morel@aphp.fr
Study Locations
-
-
-
Paris, France, 75015
- Hopital Necker-Enfants Malades
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Holders of parental authority and patients informed and not opposing their participation in the study
- Patients aged 8 to 10 years old
- native-French speakers (French from France including the French overseas departments and territories)
- Educated in France in an ordinary environment
- Patients without a cleft
- Patients with a cleft : patients with a hard and/or soft palate cleft and for whom the perceptual speech-language pathology evaluation revealed a velopharyngeal insufficiency
Exclusion Criteria:
Patients without developmental speech disorder (including articulation disorder) or hearing impairment
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Patients without cleft
Patients without developmental speech disorder (including articulation disorder) or hearing impairment
|
Repetition of several stimuli (syllables, sentences ) in the microphones of the Nasometer
|
Patients with a cleft
Patients with a hard and/or soft palate cleft and for whom the perceptual speech-language pathology evaluation revealed a velopharyngeal insufficiency
|
Repetition of several stimuli (syllables, sentences ) in the microphones of the Nasometer
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Nasalance score for each stimulus
Time Frame: Day 0
|
Average value of nasalance score for each stimulus
|
Day 0
|
Nasalance score per context
Time Frame: Day 0
|
Average value of nasalance score per context (oral - nasal)
|
Day 0
|
Nasalance score of the nasalance distance
Time Frame: Day 0
|
Average value of the nasalance distance (difference between the average in a nasal context and the average in an oral context)
|
Day 0
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Effect of the context on the nasalance scores
Time Frame: Day 0
|
Effect of the context (oral / nasal) on the nasalance scores: comparison of the mean, minimum and maximum measurements between the two contexts
|
Day 0
|
Speech stimulus length effect on the nasalance scores
Time Frame: Day 0
|
Check whether there is a speech stimulus length effect: are the nasalance scores comparable between repeating an oral short sentence and an oral long sentence, provided that the phonemic distribution is identical?
Comparison of the average, minimum and maximum scores between the two stimuli
|
Day 0
|
Effect of the phonetic context on the nasalance scores
Time Frame: Day 0
|
Check if there is an effect of the phonetic context (types of vowels and consonants) on the nasalance scores: comparison of the mean, minimum and maximum scores between for example high vowels ([i]) and low ([a]) or between voiceless ([k]) and voiced ([g]) consonants
|
Day 0
|
Test-retest reliability of the nasalance scores
Time Frame: Day 0
|
Evaluate the test-retest reliability: selection of a few subjects who will repeat the stimuli twice.
Analyze if there is a significant difference between the two repetitions
|
Day 0
|
Most relevant stimuli for a nasometric protocol
Time Frame: Day 0
|
Validate the nasometric evaluation protocol for its clinical use : on the basis of speech therapy assessment results, determine the best time / efficiency ratio and choose the most relevant stimuli in order to have the maximum information in a minimum of time
|
Day 0
|
Analysis of acoustic signals captured by standard microphones
Time Frame: Day 0
|
Compare the nasalance score obtained with the Nasometer with a nasalance score calculated on the basis of acoustic signals captured at the same time by standard microphones placed on the Nasometer plate: compare the average, minimum and maximum values between the two recordings of acoustic signals
|
Day 0
|
Collaborators and Investigators
Investigators
- Principal Investigator: Natacha KADLUB, MD, PhD, Assistance Publique - Hôpitaux de Paris
- Study Director: Cécile CHAPUIS-VANDENBOGAERDE, MD, Assistance Publique - Hôpitaux de Paris
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- APHP210445
- 2021-A00452-39 (Other Identifier: IDRCB)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Resonance Disorder
-
Xuzhou Central HospitalThe Affiliated Hospital of Xuzhou Medical UniversityNot yet recruitingFunctional Magnetic Resonance Imaging | Executive Function Disorder
-
National Institute of Neurological Disorders and...CompletedHealthy Subjects | Magnetic Resonance Imaging | Neurological Disorder | Central Nervous System | VolunteerUnited States
-
First Affiliated Hospital of Chongqing Medical...The Second Affiliated Hospital of Chongqing Medical University; Second Xiangya...RecruitingMajor Depressive Disorder | Magnetic Resonance Imaging | Electroconvulsive TherapyChina
-
BayerCompletedMagnetic Resonance Imaging | Magnetic Resonance AngiographyPoland, China, France, Germany, Hungary, Korea, Republic of, South Africa, Spain, Thailand, Taiwan, Czech Republic, Hong Kong, Italy, Kazakhstan, Russian Federation, Bosnia and Herzegovina, Greece, Canada, Vietnam, Kyrgyzstan
-
Aarhus University HospitalWithdrawnMagnetic ResonanceDenmark
-
Anhui Medical UniversityRecruitingMagnetic Resonance Imaging | Anxiety Disorder | Transcranial Alternating Current StimulationChina
-
Anhui Medical UniversityCompletedTranscranial Magnetic Stimulation | Obsessive-Compulsive Disorder | Functional Magnetic Resonance Imaging | Event-Related PotentialsChina
-
Anhui Medical UniversityRecruitingTranscranial Magnetic Stimulation | Obsessive-Compulsive Disorder | Functional Magnetic Resonance Imaging | Accelerated Continue Theta-burst StimulationChina
-
Centre Hospitalier Régional Metz-ThionvilleUniversity of LorraineRecruitingMagnetic Resonance ImagingFrance
-
Insel Gruppe AG, University Hospital BernRecruitingMagnetic Resonance SpectroscopySwitzerland